肤康搽剂治疗儿童湿疹的临床观察研究

Clinical observation of Fukang liniment in the treatment of eczema in children

ES评分 0

DOI 10.12208/j.ijcr.20230299
刊名
International Journal of Clinical Research
年,卷(期) 2023, 7(8)
作者
作者单位

甘肃武威市凉州医院 甘肃武威 ;

摘要
探究肤康搽剂对儿童湿疹的效果,为临床进行治疗提供依据。方法 选取我院2020年3月-2023年1月治疗的94例湿疹患儿,随机平均将所有病人分为肤康搽剂组(n=47)及常规组(n=47),常规组患儿使用1%氢化可的松乳膏进行涂擦,每日早晚各涂抹1次,肤康搽剂组给予肤康搽剂进行涂擦,每日3次,常规组和肤康搽剂组患儿都干预1个月,1个月后对疗效情况、症状积分、不良反应进行对比。结果 肤康搽剂组湿疹病人(病症不对)治愈的总有效率明显大于常规组(P<0.05),肤康搽剂组湿疹患儿的症状评分显著小于常规组(P<0.05),肤康搽剂组和常规组湿疹患儿在治疗期间发生不良反应的情况没有显著差异(P>0.05)。结论 肤康搽剂能够明显改善患儿湿疹的症状积分,治疗效果明显的同时不会出现明显不良反应,可在临床推广使用。
Abstract
Objective To explore the therapeutic effect of Erfukang liniment on eczema in children, and to provide evidence for clinical treatment of eczema in children. Methods According to the inclusion and exclusion criteria, 140 children with eczema treated in our hospital from March 2020 to January 2023 were randomly divided into Erfukang liniment group (n=70) and routine group (n=70). Children in the routine group were smeared with 1% hydrocortisone cream once a day in the morning and evening, and those in the Erfukang liniment group were smeared with Erfukang liniment for 3 times a day. Results The total effective rate of patients with insect bite dermatitis in Erfukang liniment group was significantly higher than that in the routine group (P < 0.05), and the symptom score of eczema children in Erfukang liniment group was significantly lower than that in the routine group (P < 0.05). There was no significant difference in adverse reactions between Erfukang liniment group and routine group during treatment (P > 0.05). Conclusion Erfukang liniment can obviously improve the symptom score of eczema in children, and the treatment effect is obvious without obvious adverse reactions, so it can be widely used in clinic.
关键词
肤康搽剂;儿童;湿疹;临床观察
KeyWord
Erfukang liniment; Children; Eczema; Clinical observation
基金项目
页码 61-64
  • 参考文献
  • 相关文献
  • 引用本文

丁晓琴*,顾明年. 肤康搽剂治疗儿童湿疹的临床观察研究 [J]. 国际临床研究杂志. 2023; 7; (8). 61 - 64.

  • 文献评论

相关学者

相关机构